|
NAA25 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51699985906362E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.21219999949763E-07 |
| Normal-vs-Stage2 |
1.950160E-02 |
| Normal-vs-Stage3 |
2.761800E-03 |
| Normal-vs-Stage4 |
3.660200E-02 |
| Stage1-vs-Stage2 |
3.746000E-01 |
| Stage1-vs-Stage3 |
5.002400E-01 |
| Stage1-vs-Stage4 |
2.680200E-01 |
| Stage2-vs-Stage3 |
6.436000E-01 |
| Stage2-vs-Stage4 |
9.384600E-01 |
| Stage3-vs-Stage4 |
5.946800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.27529999893738E-08 |
| Normal-vs-AfricanAmerican |
5.79090000000226E-05 |
| Normal-vs-Asian |
2.067200E-01 |
| Caucasian-vs-AfricanAmerican |
3.642600E-01 |
| Caucasian-vs-Asian |
8.011200E-01 |
| AfricanAmerican-vs-Asian |
6.142000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.43559999946186E-08 |
| Normal-vs-Female |
9.38590000165718E-08 |
| Male-vs-Female |
5.404400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.551800E-04 |
| Normal-vs-Extreme_Weight |
1.395560E-03 |
| Normal-vs-Obese |
1.65412999999504E-05 |
| Normal-vs-Extreme_Obese |
1.752440E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.407600E-01 |
| Normal_Weight-vs-Obese |
3.525000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.984400E-01 |
| Extreme_Weight-vs-Obese |
2.684400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.791000E-01 |
| Obese-vs-Extreme_Obese |
6.756400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.977100E-04 |
| Normal-vs-Age(41-60Yrs) |
4.48790005158628E-10 |
| Normal-vs-Age(61-80Yrs) |
2.21069999999379E-05 |
| Normal-vs-Age(81-100Yrs) |
5.280000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.217000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.976300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.124300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.229410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.357900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.601800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.82729950562555E-10 |
| Normal-VS-Type2 PRCC |
5.265900E-02 |
| Normal-VS-KIRP CIMP |
1.607500E-02 |
| Normal-VS-Unclassified PRCC |
1.404250E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.862550E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.669790E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.683200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.046000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.316200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.796240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.634380E-02 |
| Normal-vs-N1 |
5.406600E-04 |
| Normal-vs-N2 |
8.767500E-04 |
| N0-vs-N1 |
5.520600E-03 |
| N0-vs-N2 |
1.629400E-01 |
| N1-vs-N2 |
5.326200E-01 |
|
|
